Skip to main content
Figure 5 | Molecular Medicine

Figure 5

From: Antiangiogenic and Antitumoral Effects Mediated by a Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1)-Targeted DNAzyme

Figure 5

Effect of DT18 on tumor vasculature assayed by DCE-MRI. MRI was performed 3 d after the DT18 treatment on superconducting magnetic resonance imaging scanners (GE Signa HDx 3.0T) with 2.0 inches coil (FT-AN). Gd-DTPA, a blood-pool contrast agent, was injected via the tail-vein catheter. The representative images were presented (A). Ktrans was generated from raw data of DCE-MRI by using NordicICE software (version 2.3.6) (B). Values are the means ± SE of three replicates. *P < 0.05 compared with the control.

Back to article page